Robert W. Schrier

Active 1966–2024

Also published as
ROBERT W. SCHRIER
223
Papers
48,303
Citations
118
h-index
222
i10-index

Citations

Citations per year for Robert W. Schrier1967: 1 citations1968: 1 citations1970: 4 citations1971: 3 citations1972: 16 citations1973: 18 citations1974: 26 citations1975: 18 citations1976: 20 citations1977: 16 citations1978: 30 citations1979: 29 citations1980: 34 citations1981: 28 citations1982: 56 citations1983: 29 citations1984: 60 citations1985: 57 citations1986: 52 citations1987: 56 citations1988: 86 citations1989: 47 citations1990: 73 citations1991: 78 citations1992: 66 citations1993: 53 citations1994: 77 citations1995: 113 citations1996: 90 citations1997: 112 citations1998: 203 citations1999: 141 citations2000: 188 citations2001: 219 citations2002: 255 citations2003: 353 citations2004: 305 citations2005: 297 citations2006: 334 citations2007: 341 citations2008: 387 citations2009: 330 citations2010: 350 citations2011: 286 citations2012: 311 citations2013: 278 citations2014: 295 citations2015: 261 citations2016: 215 citations2017: 225 citations2018: 169 citations2019: 703 citations2020: 611 citations2021: 581 citations2022: 526 citations2023: 357 citations2024: 582 citations2025: 296 citations2026: 12 citations1969: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,661 citing papers, 31.1% of this breakdownUnited Kingdom: 741 citing papers, 6.3% of this breakdownItaly: 639 citing papers, 5.4% of this breakdownGermany: 582 citing papers, 4.9% of this breakdownChina: 556 citing papers, 4.7% of this breakdownCanada: 500 citing papers, 4.3% of this breakdownNetherlands: 442 citing papers, 3.8% of this breakdownAustralia: 438 citing papers, 3.7% of this breakdownJapan: 413 citing papers, 3.5% of this breakdownFrance: 402 citing papers, 3.4% of this breakdownSpain: 393 citing papers, 3.3% of this breakdownBelgium: 246 citing papers, 2.1% of this breakdown
0%31.1%Other 23.5%

Fields

  • Medicine74.1%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Neuroscience1.2%
  • Nursing1%
  • Immunology and Microbiology1%
  • Psychology0.9%
  • Other3.3%

Topics

  • Electrolyte and hormonal disorders4.3%
  • Acute Kidney Injury Research4.2%
  • Chronic Kidney Disease and Diabetes3.4%
  • Blood Pressure and Hypertension Studies3.3%
  • Genetic and Kidney Cyst Diseases3.2%
  • Liver Disease and Transplantation2.9%
  • Other78.7%

Coauthors

All papers

Open in search
  1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Koon Teo, Carl J. Pepine, Barry R. Davis - The Lancet 2021 cited by 1,001

  2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rury R. Holman, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Mark Woodward, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Barry R. Davis and 2 more - The Lancet 2021 cited by 321

  3. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eduardo Verde, Eduardo Gutiérrez, Enyu Imai, Fan Fan Hou, Fernando Caravaca, Fernando C. Fervenza, Francesco Locatelli, Francesco Paolo Schena, Fumiaki Kobayashi, Gabriella Moroni, Gavin J. Becker, Gerald J. Beck, Gerald B. Appel, Gershon Frisch, GG van Essen, Giuseppe Maschio, Giuseppe Remuzzi, Giuseppe Montogrino, Hans‐Henrik Parving, Hiddo J.L. Heerspink, Hirofumi Makino, Imitiaz Jehan, Jack F.M. Wetzels, James V. Donadío, Jamie P. Dwyer, Jan A.J.G. van den Brand, John W. Kusek, John M. Lachin, José Luño, Julia B. Lewis, Jürgen Floege, Kaleab Z. Abebe, K.-M. Chow, Lawrence G. Hunsicker, Lucia Del Vecchio, Manno Carlo, Manuel Praga, Marián Goicoechea, Maximilian von Eynatten, Neil Poulter, Nish Chaturvedi, Patrizia Passerini, Paul E. de Jong, Peter J. Blankestijn, Philip H. Li, Piero Ruggenenti, P Zucchelli, Priscilla Kincaid‐Smith, R.-D Hilgers, Raymond O. Estacio, Richard D. Rohde, Ritsuko Katafuchi, Robert D. Toto, Robert W. Schrier, Roger A. Rodby, Ronald D. Perrone, Sadayoshi Ito, Saulo Klahr, Simeone Andrulli, Svend Strandgaard, Tak Mao Chan, Thierry Hannedouche, Thomas Rauen, Tom Greene, Úrsula Verdalles, Vlado Perkovic, William F. Keane - The Lancet Diabetes & Endocrinology 2019 cited by 372

  4. Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations

    Authors: , , , , , , - The American Journal of Medicine 2013 cited by 1,177

  5. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , - Kidney International 2015 cited by 605

  6. Acute Renal Failure and Sepsis

    Authors: , - New England Journal of Medicine 2004 cited by 1,253

  7. Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 517

  8. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J A Cutler, Richard B Devereaux, Jamie P. Dwyer, R Estacio, Robert Fagard, Keith A.A. Fox, Tomohiro FUKUI, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Marc Allan Pfeffer, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi‐Khorshidi, Johan Sundström and 3 more - The Lancet Diabetes & Endocrinology 2022 cited by 102

  9. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

    Authors: , , , , , - Hepatology 1988 cited by 1,623

  10. Glomerular hyperfiltration: definitions, mechanisms and clinical implications

    Authors: , , , - Nature Reviews Nephrology 2012 cited by 665

  11. Hormones and Hemodynamics in Heart Failure

    Authors: , - New England Journal of Medicine 1999 cited by 1,197

  12. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy

    Authors: , , , , , , , , , , , - Kidney International 1998 cited by 531

  13. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Estacio, Robert Fagard, Kim Fox, Takahiro Fukui, Ajay Gupta, Rury R. Holman, Y. Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Jeff Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, G. Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Carl J. Pepine, Michael Pfeffer, N. Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter S. Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, L. Wing, Mark Woodward, Yoshiaki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Richard Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi and 4 more - The Lancet Oncology 2021 cited by 104

  14. Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia

    Authors: , , , , , , - New England Journal of Medicine 2006 cited by 1,212

  15. Genotype–Phenotype Correlation in X-Linked Alport Syndrome

    Authors: , , , , , , - Journal of the American Society of Nephrology 2010 cited by 285

  16. Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 286

  17. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 182

  18. Renal Failure in Cirrhosis

    Authors: , - New England Journal of Medicine 2009 cited by 831

  19. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

    Authors: , , , - Kidney International 2002 cited by 850

  20. Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis

    Authors: , , - New England Journal of Medicine 1998 cited by 445

  21. The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

    Authors: , , , , , - New England Journal of Medicine 1998 cited by 1,178

  22. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

    Authors: , , , - 2000 cited by 696

  23. Interstitial Vascular Rarefaction and Reduced VEGF-A Expression in Human Diabetic Nephropathy

    Authors: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 241

  24. Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , - Clinical Journal of the American Society of Nephrology 2014 cited by 177